PineBridge Investments’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$992K Sell
6,610
-625
-9% -$68K 0.01% 432
2026
Q1
$668K Buy
+7,235
New +$726K 0.01% 414
2022
Q2
Sell
-100
Closed -$7K 751
2022
Q1
$7K Sell
100
-300
-75% -$20.5K ﹤0.01% 662
2021
Q4
$40K Buy
+400
New +$41.4K ﹤0.01% 732

Other funds holding GH

PineBridge Investments's GH Position: Q2 2026 in Review

PineBridge Investments reduced its Guardant Health (GH) stake by 8.6% in Q2 2026, selling an estimated $68K and leaving 6,610 shares worth $992K. The position accounts for 0.01% of the portfolio, ranked #432.

PineBridge Investments first reported a position in GH in Q4 2021 and has held it in 4 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • PineBridge Investments held 6,610 shares of Guardant Health worth $992K as of Q2 2026.
  • PineBridge Investments sold 625 Guardant Health shares in Q2 2026, an estimated $68K.
  • Guardant Health made up 0.01% of PineBridge Investments's portfolio in Q2 2026, its #432 holding.
  • PineBridge Investments first reported a position in Guardant Health in Q4 2021 and has held it in 4 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on PineBridge Investments's 13F filing for Q2 2026, filed 14 Aug 2026.